Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Ratio: 2009-2024

Historic Equity Ratio for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to 0.30.

  • Cumberland Pharmaceuticals' Equity Ratio rose 22.76% to 0.40 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40, marking a year-over-year increase of 22.76%. This contributed to the annual value of 0.30 for FY2024, which is 16.48% down from last year.
  • Cumberland Pharmaceuticals' Equity Ratio amounted to 0.30 in FY2024, which was down 16.48% from 0.36 recorded in FY2023.
  • Cumberland Pharmaceuticals' Equity Ratio's 5-year high stood at 0.51 during FY2021, with a 5-year trough of 0.30 in FY2024.
  • For the 3-year period, Cumberland Pharmaceuticals' Equity Ratio averaged around 0.35, with its median value being 0.36 (2023).
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Equity Ratio climbed by 4.06% in 2021, and later dropped by 23.01% in 2022.
  • Yearly analysis of 5 years shows Cumberland Pharmaceuticals' Equity Ratio stood at 0.49 in 2020, then increased by 4.06% to 0.51 in 2021, then dropped by 23.01% to 0.39 in 2022, then dropped by 7.24% to 0.36 in 2023, then dropped by 16.48% to 0.30 in 2024.